Nakata index above 1500 mm2/m2 predicts death in absent pulmonary valve syndrome.


Journal

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
ISSN: 1873-734X
Titre abrégé: Eur J Cardiothorac Surg
Pays: Germany
ID NLM: 8804069

Informations de publication

Date de publication:
01 01 2020
Historique:
received: 12 12 2018
revised: 16 04 2019
accepted: 24 04 2019
pubmed: 11 6 2019
medline: 22 6 2021
entrez: 11 6 2019
Statut: ppublish

Résumé

Absent pulmonary valve syndrome is a rare congenital heart disease with severe airway compression due to dilatation of the pulmonary arteries (PAs). We investigated risk factors for death and prolonged mechanical ventilation (>7 days) and a threshold PA size for these outcomes. This retrospective 2-centre cohort study included 68 patients with complete repair between January 1996 and December 2015. Median age at repair was 3.9 months (1.3-8.7 months), and median weight was 5 kg (4-7 kg). The mortality rate before hospital discharge was 12%, and the mortality rate at last follow-up was 19%. In multivariable analysis, risk factors for death were higher Nakata index [hazard ratio (HR) 1.001, 95% confidence interval (CI) 1.001-1.002; P < 0.001] and lower SpO2 (HR 1.06, 95% CI 1.02-1.09; P = 0.002). The accuracy of the Nakata index to predict death was excellent (area under the curve at 6 months: 0.92; P = 0.010). A Nakata index above 1500 mm2/m2 predicted mortality at 6 months with a sensitivity of 98% and a specificity of 82%. Twenty-five patients (37%) had prolonged mechanical ventilation. The only multivariable risk factor for prolonged ventilation was lower weight at repair (odds ratio 2.9, 95% CI 1.3-6.7; P = 0.008). Neither PA plasty nor the LeCompte manoeuvre had a protective effect on mortality or prolonged ventilation. A Nakata index above 1500 mm2/m2 remained a risk factor for mortality (P = 0.022) in patients who had a PA plasty or the LeCompte manoeuvre. In patients with absent pulmonary valve syndrome, the Nakata index predicts mortality with a cut-off of 1500 mm2/m2. Lower weight at repair is the only multivariable risk factor for prolonged ventilation. Neither PA plasty nor the LeCompte manoeuvre had a protective effect on these outcomes.

Identifiants

pubmed: 31180449
pii: 5513234
doi: 10.1093/ejcts/ezz167
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

46-53

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Auteurs

Yasemin Karaca-Altintas (Y)

Department of Pediatric and Congenital Cardiac Surgery, M3C, Hôpital Marie Lannelongue, Le Plessis Robinson, France.
CHU Lille, Pediatric Intensive Care Unit, Lille, France.

Daniela Laux (D)

Department of Pediatric and Congenital Cardiac Surgery, M3C, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Marielle Gouton (M)

Department of Pediatric and Congenital Cardiac Surgery, M3C, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Myriam Bensemlali (M)

M3C-Necker, National Reference Center for Complex Congenital Heart Defects, Hôpital Universitaire Necker-Enfants malades, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Régine Roussin (R)

Department of Pediatric and Congenital Cardiac Surgery, M3C, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Jürgen Hörer (J)

Department of Pediatric and Congenital Cardiac Surgery, M3C, Hôpital Marie Lannelongue, Le Plessis Robinson, France.

Olivier Raisky (O)

M3C-Necker, National Reference Center for Complex Congenital Heart Defects, Hôpital Universitaire Necker-Enfants malades, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Damien Bonnet (D)

M3C-Necker, National Reference Center for Complex Congenital Heart Defects, Hôpital Universitaire Necker-Enfants malades, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH